A strategic guide to patent expiry, lifecycle defense, and the economics of generic competition — for executives, investors, and analysts […]
What Happens When a Drug Patent Expires? Understanding Drug Patent Life Read Post »
1. What a Tentative Approval Actually Means (and What It Doesn’t) A Tentative Approval (TA) letter from the FDA means
FDA Tentative Approval: The Generic Drug Strategist’s Complete Playbook Read Post »
In the intricate and often turbulent landscape of the American healthcare system, pharmacists stand as the most accessible healthcare professionals,
In the Eye of the Storm: How Pharmacists Are Trapped in the Middle of Drug Price Wars Read Post »
Every year, dozens of brand-name drugs approach the end of their patent life with billions in annual revenue at stake.
Tentative Drug Approvals: The Definitive Generic Entry Forecasting Playbook Read Post »
How the incentive architecture behind pharmaceutical R&D shapes pipeline decisions, drug pricing, access policy, and $2 trillion in annual investment,
Drug Patents vs. Prize Models: The Complete IP Strategy Guide for Pharma Innovation Read Post »
Every year, the pharmaceutical industry discards hundreds of compounds with known safety profiles, established pharmacokinetics, and years of preclinical data.
Drug Repositioning: The Complete IP, Regulatory, and Investment Playbook Read Post »
Executive Summary Pfizer’s management of sildenafil citrate’s loss of exclusivity (LOE) in the United States is the closest thing small-molecule
Viagra’s Generic Cliff: Why It Wasn’t a Free-for-All Read Post »
Drugs can have many patents and regulatory protections Drugs can be covered by myriad patents and regulatory protections. Even Aspirin,
Why Asia is the New Biosimilar Battleground The Patent Cliff Meets a Demographic Supercycle The most consequential commercial event in
Get fresh news and insights, drug patent expirations & more…
